<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="131" ids="25107">Magnesium</z:chebi> deficiency is associated with a high frequency of <z:hpo ids='HP_0011675'>cardiac arrhythmia</z:hpo>, <z:hpo ids='HP_0000822'>hypertension</z:hpo> and sudden ischemic <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated the if vivo effects of intravenous <z:chebi fb="131" ids="25107">magnesium</z:chebi> administration in a rat model of chemically induced (<z:chebi fb="0" ids="30808">FeCl3</z:chebi>) carotid <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>The infusion of <z:chebi fb="0" ids="32599">magnesium sulfate</z:chebi> (<z:chebi fb="0" ids="32599">MgSO4</z:chebi>) before the topical application of FeCl5 prevented <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation at concentrations of 0.3 M and 0.6 M, and delayed it even at 0.15 M </plain></SENT>
<SENT sid="3" pm="."><plain>Similar results were obtained with <z:chebi fb="0" ids="6636">MgCl2</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>The infusion of <z:chebi fb="0" ids="32599">MgSO4</z:chebi> 0.6 M seven minutes after <z:chebi fb="0" ids="30808">FeCl3</z:chebi> application delayed but did not prevent <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="32599">MgSO4</z:chebi> slightly <z:mp ids='MP_0009549'>reduced platelet aggregation</z:mp> ex vivo without affecting plasma clotting tests, but in vivo blood clotting time was markedly prolonged (tail transection method), thus indicating profoundly impaired coagulation </plain></SENT>
<SENT sid="6" pm="."><plain>These data provide a rationale for the use of <z:chebi fb="131" ids="25107">magnesium</z:chebi> as an antithrombotic agent. but its pharmacological effect critically depends on the timing of administration </plain></SENT>
</text></document>